HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bucillamine induces glutathione biosynthesis via activation of the transcription factor Nrf2.

Abstract
The properties of bucillamine, a synthetic antioxidant, have been attributed mainly to the donation of thiol groups to glutathione (GSH). We recently demonstrated that glutamate-cysteine ligase catalytic subunit (GCLC), the rate-limiting enzyme of GSH biosynthesis, and the multidrug-resistance-associated protein 2 (Mrp2/MRP2) are coordinately induced in response to xenobiotic through the activation of the antioxidant-response element (ARE) by nuclear factor-erythroid 2 p45-related factor (Nrf2). We tested the hypothesis that bucillamine and its oxidized metabolite SA 981 also activate the Nrf2 pathway, thereby increasing glutathione biosynthesis in human HepG2 and murine Hepa 1-6 hepatoma cell lines, through the induction of the GCLC enzyme as well as the Mrp2/MRP2 transporter, which mediates the excretion of glutathione and its conjugates from hepatocytes. Both bucillamine and SA 981 produced a significant dose-dependent increase in the mRNA levels of Mrp2/MRP2 and GCLC after 24 h. The levels of the transcription factor Nrf2 in the nuclei were maximal at 3 h, remained elevated at 6 h, and decreased to control values at 24 h in both cell lines. Moreover, both bucillamine and SA 981 significantly increased the expressions of Mrp2/MRP2 and GCLC proteins in both cell lines. Finally, in both cell lines, bucillamine and SA 981 increased the GSH content two- to three-fold. These results demonstrate that bucillamine and SA 981 activate the ARE-ARE pathway increasing the expression of ARE-driven genes such as those of GCLC and Mrp2/MRP2. The role of bucillamine as a chemopreventive agent against cancer remains to be elucidated.
AuthorsAna M Wielandt, Valeska Vollrath, Marcelo Farias, Jose Chianale
JournalBiochemical pharmacology (Biochem Pharmacol) Vol. 72 Issue 4 Pg. 455-62 (Aug 14 2006) ISSN: 0006-2952 [Print] England
PMID16806086 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • ABCC2 protein, human
  • Membrane Transport Proteins
  • Multidrug Resistance-Associated Protein 2
  • Multidrug Resistance-Associated Proteins
  • NF-E2 Transcription Factor, p45 Subunit
  • RNA, Messenger
  • bucillamine disulfide
  • Glutamate-Cysteine Ligase
  • Glutathione
  • Cysteine
  • bucillamine
Topics
  • Active Transport, Cell Nucleus (drug effects)
  • Animals
  • Blotting, Northern
  • Blotting, Western
  • Carcinoma, Hepatocellular (genetics, metabolism, pathology)
  • Catalytic Domain (genetics)
  • Cell Line, Tumor
  • Cell Nucleus (drug effects, metabolism)
  • Cysteine (analogs & derivatives, chemistry, pharmacology)
  • Gene Expression (drug effects, genetics)
  • Glutamate-Cysteine Ligase (genetics, metabolism)
  • Glutathione (biosynthesis)
  • Humans
  • Membrane Transport Proteins (genetics, metabolism)
  • Molecular Structure
  • Multidrug Resistance-Associated Protein 2
  • Multidrug Resistance-Associated Proteins (genetics, metabolism)
  • NF-E2 Transcription Factor, p45 Subunit (genetics, metabolism)
  • RNA, Messenger (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: